From: Gender and thrombolysis therapy in stroke patients with incidence of dyslipidemia
 | B Value | Wald | Odds Ratio | 95% C.I. Lower | For OR Upper | P Value |
---|---|---|---|---|---|---|
Age | 0.012 | 2.210 | 1.012 | 0.996 | 1.028 | 0.137 |
BMI | -0.008 | 0.414 | 0.992 | 0.967 | 1.017 | 0.520 |
NIH Stroke Scale | -0.125 | 17.336 | 0.882 | 0.832 | 0.936 | <0.001* |
Risk of Mortality GWTG | 0.069 | 3.302 | 1.071 | 0.995 | 1.153 | 0.069 |
Gender | 0.516 | 8.838 | 1.675 | 1.192 | 2.354 | 0.003* |
Race | 0.181 | 0.821 | 1.198 | 0.810 | 1.773 | 0.365 |
Atrial Fibrillation | 0.592 | 6.350 | 1.807 | 1.140 | 2.862 | 0.012* |
Coronary Artery Disease | 0.136 | 0.520 | 1.145 | 0.792 | 1.655 | 0.471 |
Carotid Artery Stenosis | 1.108 | 10.309 | 3.030 | 1.540 | 5.960 | 0.001* |
Diabetes | 0.380 | 1.442 | 1.462 | 0.787 | 2.716 | 0.230 |
Congestive Heart Failure | 0.260 | 0.979 | 1.296 | 0.775 | 2.168 | 0.322 |
Hypertension | -0.247 | 0.577 | 0.781 | 0.412 | 1.479 | 0.448 |
Previous Stroke | 0.614 | 10.591 | 1.847 | 1.276 | 2.673 | 0.001* |
Previous TIA | -0.311 | 1.514 | 0.733 | 0.447 | 1.202 | 0.219 |
Peripheral Vascular Disease | 0.062 | 0.043 | 1.064 | 0.590 | 1.921 | 0.836 |
History of Smoking | -0.337 | 2.308 | 0.714 | 0.462 | 1.103 | 0.129 |
Antiplatelet medication | -0.291 | 2.188 | 0.747 | 0.508 | 1.099 | 0.139 |
Antihypertensive medication | -0.618 | 4.786 | 0.539 | 0.310 | 0.938 | 0.029* |
Cholesterol Reducer | -0.187 | 0.813 | 0.829 | 0.552 | 1.246 | 0.367 |
Antidiabetic medication | -0.091 | 0.074 | 0.913 | 0.474 | 1.759 | 0.785 |